Showing 1 - 10 of 3,254
This paper is the first to estimate the impact of exposure to deceptive advertising on consumption of the advertised product and its substitutes. We study the market for over-the-counter (OTC) weight-loss products, a market in which deceptive advertising is rampant and products are generally...
Persistent link: https://www.econbiz.de/10009717705
Persistent link: https://www.econbiz.de/10003985108
Persistent link: https://www.econbiz.de/10009745219
Persistent link: https://www.econbiz.de/10009630754
We study the effect of price caps on the provision of costly effort by pharmaceutical firms using variation in drug discounts generated by a price regulation program that allows eligible hospitals to purchase outpatient drugs at steep discounts. These discounts directly affect drug...
Persistent link: https://www.econbiz.de/10014512103
Persistent link: https://www.econbiz.de/10003977116
Persistent link: https://www.econbiz.de/10003995704
Persistent link: https://www.econbiz.de/10009486392
The United States spends twice as much per person on pharmaceuticals as European countries, in large part because prices are much higher in the US. This fact has led policymakers to consider legislation for price controls. This paper assesses the effects of a US international reference pricing...
Persistent link: https://www.econbiz.de/10013210081
In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important federal legislation, institutional details regarding distribution channel logistics, definitions of alternative price measures, related historical...
Persistent link: https://www.econbiz.de/10014191301